CDC Changes Hepatitis B Vaccine Recommendation for Newborns
On December 16, the U.S. Centers for Disease Control and Prevention (CDC) announced a significant change to its recommendations regarding the hepatitis B vaccine for newborns. Previously, it was suggested that all infants receive the vaccine; now, the decision is left to parents, in discussion with healthcare providers, particularly for those born to mothers who are hepatitis B-negative.
This shift comes after a recommendation from Health Secretary Robert F. Kennedy Jr.’s advisory panel, which suggests that the birth dose of the vaccine should only be given to babies whose mothers test positive for hepatitis B or whose status is unclear. The CDC has adopted this new policy.
If parents opt against vaccinating their newborn right after birth but still believe it’s necessary, the CDC now advises waiting at least two months for the first dose.
Since 1991, U.S. health authorities have advocated for universal vaccination of infants against hepatitis B, starting with a shot soon after birth. This alteration in recommendations significantly impacts health insurance coverage in the U.S. and influences how doctors select vaccines for their patients.
However, some experts have raised concerns about the updated guidelines. They argue that this individual-centered decision-making process might expose more children to the virus and could lead to more families forgoing vaccination due to a lack of a cohesive federal policy. Notably, Kennedy has been an advocate against vaccinations and has introduced substantial changes to U.S. vaccination policies.
Dr. Emily Landon, an infectious diseases specialist at the University of Chicago Medicine, criticized the CDC’s decision. She emphasized that the advisory panel should help clinicians sift through scientific evidence to make informed care decisions. “This recommendation overlooks the science. It indicates a move away from science-driven guidelines for improving public health,” she stated.
Hepatitis B can result in severe liver disease, primarily transmitted through blood and certain bodily fluids. It’s also possible for it to spread through close contact with asymptomatic individuals, such as caregivers or friends.
Since widespread vaccination began, hepatitis B infections in the U.S. have plummeted nearly 90%, dropping from 9.6 per 100,000 people to about one per 100,000 in 2018.
Moreover, the CDC is currently reviewing the panel’s suggestion that parents should discuss antibody testing with their healthcare provider to determine if an additional dose of the hepatitis B vaccine is necessary.
